PledPharma reports positive top-line Phase IIb trial results of colorectal cancer drug PledOx
FOLFOX is a combination of the drugs folinic acid, 5-fluorouracil and oxaliplatin. A total of 173 patients were included in the trial, which was conducted at about 30